List of works by Isabelle Huys

"Trust is not something you can reclaim easily": patenting in the field of direct-to-consumer genetic testing

scientific article published on 22 November 2012

A bacteriophage journey at the European Medicines Agency

scientific article published on 10 December 2015

Access to biobanks: harmonization across biobank initiatives

scientific article published on 01 December 2014

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium

scientific article published on 7 April 2015

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

scientific article

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

scientific article published on 01 January 2020

Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012

scientific article published on 16 February 2017

Biosimilars and market access: a question of comparability and costs?

scientific article published on 17 January 2012

Biosimilars in Belgium: a proposal for a more competitive market

scientific article published on 13 May 2020

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems

scientific article published on 20 September 2013

Call for a dedicated European legal framework for bacteriophage therapy.

scientific article published on 06 February 2014

Causes of drug shortages in the legal pharmaceutical framework

scientific article published on 12 January 2015

Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.

scientific article published on 6 October 2015

Clinical, Economic and Policy Implications of Drug Shortages in the European Union.

scientific article published on August 2016

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

scientific article published on 03 December 2019

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.

scientific article

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2-Biosimilar and Originator Etanercept in the Outpatient Setting.

scientific article

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

scientific article

Economic evaluation of biosimilars for reimbursement purposes - what, when, how?

scientific article published on 15 March 2020

European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption

scientific article published on 03 November 2020

European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice

scientific article published on 15 October 2020

European drug shortages: a call for action!

scientific article

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

scientific article published on 5 April 2018

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

scientific article published on 18 September 2019

Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

scientific article published on 26 September 2018

Financial based agreements and performance based agreements: the Belgian experience.

scientific article published on 5 October 2015

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law

scientific article

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

scientific article published on 01 April 2020

Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders' Perspectives: Systematic Review

scientific article published on 08 October 2020

Improving Patient Preference Elicitation by Applying Concepts From the Consumer Research Field: Narrative Literature Review

scientific article published on 31 March 2020

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs

scientific article

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

article

Innovative Approaches to Increase Access to Medicines in Developing Countries

scientific article published on 7 December 2017

Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs)

scientific article

Insights into European drug shortages: a survey of hospital pharmacists

scientific article

Intellectual property policies in early-phase research in public-private partnerships

scientific article published in May 2016

Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting.

scientific article published on 11 April 2013

Legal uncertainty in the area of genetic diagnostic testing

scientific article published on 01 October 2009

Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

scientific article

Market access of cancer drugs in European countries: improving resource allocation

scientific article

Market entry of biosimilar low-molecular-weight heparins in Europe: opportunities and challenges

scientific article published on 12 December 2012

Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review

scientific article published on 08 May 2019

Noninvasive prenatal testing: a survey of young (future) parents in Flanders

scientific article published on 01 January 2018

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

scientific article published on 01 January 2019

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

scientific article published on 04 October 2019

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

scientific article published on 17 April 2012

Patient Centricity in Patient Preference Studies: The Patient Perspective

scientific article published on 20 March 2020

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice

article

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

scientific article published on 01 October 2019

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

scientific article published on 18 October 2013

Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.

scientific article

Policies for biosimilar uptake in Europe: An overview.

scientific article published on 28 December 2017

Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013.

scientific article published on 15 May 2015

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications

scientific article published on 26 March 2020

Protection of Phage Applications in Crop Production: A Patent Landscape

scientific article published on 19 March 2019

Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium

scientific article

Qualitative study on custodianship of human biological material and data stored in biobanks

scientific article

Quality and safety requirements for sustainable phage therapy products

scientific article published on 14 January 2015

Repurposing Drugs in Oncology: Next Steps

scientific article published on 12 July 2017

Repurposing drugs in oncology: From candidate selection to clinical adoption

scientific article published on 23 January 2020

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective

scientific article published on 11 February 2020

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.

scientific article published in January 2017

Taking bacteriophage therapy seriously: a moral argument

scientific article

The European BRCA patent oppositions and appeals: coloring inside the lines

scientific article published in August 2013

The Magistral Phage

scientific article published on 6 February 2018

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

scientific article

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

scientific article published on 10 November 2010

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

scientific article published on 01 July 2019

The efficacy, safety and immunogenicity of switching between reference biopharmaceuticals and biosimilars: a systematic review

scientific article published on 31 March 2020

The fate and future of patents on human genes and genetic diagnostic methods

scientific article published on 18 May 2012

The necessity for a European definition of drug shortages

scientific article published on 01 August 2018

Time Investment in Drug Supply Problems by Flemish Community Pharmacies

scientific article published on 23 August 2017

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study

scientific article

Toward a European definition for a drug shortage: a qualitative study

scientific article

Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology

scientific article published on 29 January 2018

Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies

scientific article published on 01 April 2019

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

scientific article published on 05 February 2020

What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population

scientific article published on 01 December 2019

Paulina is supported by:

About Paulina

Help